Housing arrangements for infusion pumps

Information

  • Patent Grant
  • 11801342
  • Patent Number
    11,801,342
  • Date Filed
    Thursday, July 19, 2018
    6 years ago
  • Date Issued
    Tuesday, October 31, 2023
    a year ago
Abstract
An infusion pump, including a housing, a user interface, a motor and a set of drive components, and a controller. The housing enables selective stacked attachment with other infusion pumps. The housing includes a top portion with a handle integrated into an outer surface that partially defines a generally U-shaped retaining feature. The housing also includes a bottom portion with a generally U-shaped projection that is contoured to selectively mate with the retaining feature of another infusion pump. The user interface provides a front side to the housing that receives commands regarding infusion pump operation. The motor and set of drive components are at least partially located within the housing and mechanically direct infusion of infusate. The controller is located within the housing and that controls operation of the motor and the set of drive components.
Description
TECHNICAL FIELD

Embodiments relate generally to medical devices and, more particularly, to housing arrangements for infusion pumps in the form of syringe pumps and large volume pumps (LVPs).


BACKGROUND

In the medical arts, infusion pumps have been useful for managing the delivery and dispensation of a prescribed amount or dose of a drug, fluid, fluid-like substance, or medicament (hereinafter, collectively, an “infusate”) to patients. Infusion pumps can provide some significant advantages over manual infusion techniques, by accurately delivering and dispensing infusates over an extended period of time.


Infusion pumps are particularly useful for treating diseases and disorders that require regular pharmacological intervention, including cancer, diabetes, and vascular, neurological, and metabolic disorders. They also enhance the ability of healthcare providers to deliver anesthesia and manage pain. Infusion pumps are used in various settings, including hospitals, nursing homes, and other short-term and long-term medical facilities, as well as in residential care settings. Infusion pumps can include various constructions, modes of operation, and types.


Generally, infusion pumps can include a variety of types of pumps. In some cases, these infusion pumps include syringe pumps and LVPs. Depending upon their specific designs and intended uses, infusion pumps can be used to administer infusates through various delivery methods and routes, including intravenously, intraperitoneally, enterally, intra-arterially, subcutaneously, neuraxially, and specifically into an intraoperative site, epidural space, and subarachnoid space.


While various syringe pumps and LVPs have been used in medical environments for many years, these devices remain rather complex medical devices with some limitations to their efficient, effective, and safe use. Therefore, there is a need for syringe pumps and LVPs which provide greater flexibility and ease of use to operators. Moreover, due to the vital role of infusion pumps in many medical procedures and treatments, syringe pumps and LVPs which provide enhanced safety to patients are needed as well.


SUMMARY

Embodiments described or otherwise contemplated herein substantially provide the advantages of improving flexibility, ease of use, operation, as well as patient safety, among other advantages.


An embodiment relates to an infusion pump, including a housing, a user interface, a motor and a set of drive components, and a controller. The housing enables selective stacked attachment with other infusion pumps. The housing includes a top portion with a handle integrated into an outer surface that partially defines a generally U-shaped retaining feature. The housing also includes a bottom portion with a generally U-shaped projection contoured to selectively mate with a retaining feature of another infusion pump. The user interface provides a front side to the housing that receives commands regarding infusion pump operation. The motor and set of drive components are at least partially located within the housing and mechanically direct infusion of an infusate. The controller is located within the housing and controls operation of the motor and the set of drive components.


An embodiment relates to a syringe pump, including a syringe receptacle, a syringe plunger driver assembly, and a housing. The syringe receptacle is configured to receive a syringe of an infusate. The syringe plunger driver assembly is located adjacent the syringe receptacle and directs the infusate from the syringe to a patient based on movement and force against a plunger of the syringe. The housing is coupled with the syringe receptacle and has a front side that includes a graphical user interface (GUI) display for controlling the syringe pump. The syringe receptacle is located on the front side of the housing vertically adjacent the GUI display in non-overlapping and non-visually obscuring alignment. The housing is configured such that both the syringe in the syringe receptacle and the entire GUI display are substantially visible on the front side of the housing.


An embodiment includes an infusion pump assembly. The infusion pump assembly includes a first infusion pump having a housing and a user interface with a display screen. The infusion pump assembly also has a “headless” infusion pump having no display screen. The headless infusion pump is releasably coupled to the housing of the first infusion pump by tongue-and-groove attachment.


An embodiment relates to a “field replaceable unit” for infusion pumps. The field replaceable unit includes a rear housing for an infusion pump. The rear housing includes a top portion and a bottom portion. The top portion has an integrally formed handle structure and a set of grooves. The bottom portion has a projection for releasable coupling with grooves in another rear housing. The rear housing includes a power receptacle and an Ethernet port. The rear housing interchangeably couples with a set of medication delivery components, a control system, and a display of either a LVP or a syringe pump.


The above summary is not intended to describe each illustrated embodiment or every implementation of the subject matter hereof. The figures and the detailed description that follow more particularly exemplify various embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

Subject matter hereof may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying figures, in which:



FIG. 1 is front perspective view of a syringe pump, according to an embodiment.



FIG. 2 is a rear perspective view of a syringe pump, according to an embodiment.



FIG. 3 is a front view of a syringe pump, according to an embodiment.



FIG. 4 is a rear view of a syringe pump, accordingly to an embodiment.



FIG. 5 is a top view of a syringe pump, according to an embodiment.



FIG. 6 is a bottom view of a syringe pump, according to an embodiment.



FIG. 7 is a general system diagram of a syringe pump, according to an embodiment.



FIG. 8 is front perspective view of a LVP, according to an embodiment.



FIG. 9 is a rear perspective view of a LVP, according to an embodiment.



FIG. 10 is a front view of a LVP, according to an embodiment.



FIG. 11 is a rear view of a LVP, accordingly to an embodiment.



FIG. 12 is a top view of a LVP, according to an embodiment.



FIG. 13 is a bottom view of a LVP, according to an embodiment.



FIG. 14 is a general system diagram of a LVP, according to an embodiment.



FIG. 15 is a perspective view of an example of an FRU comprising a rear housing portion for a syringe pump or LVP, according to an embodiment.



FIG. 16A is a perspective view of a racking arrangement of infusion pumps, according to an embodiment.



FIG. 16B is a perspective view of a stacking arrangement of infusion pumps, according to an embodiment.



FIG. 17 is a perspective view of an infusion pump arrangement having an external backup battery pack, according to an embodiment.



FIG. 18 is a perspective view of a stacking arrangement of a LVP with other “headless” LVPs, according to an embodiment.





While various embodiments are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the claimed subject matter to particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter as defined by the claims.


DETAILED DESCRIPTION OF THE DRAWINGS

In FIGS. 1-7, various views of an infusion pump in the form of a syringe pump 100 are shown. Similarly, in FIGS. 8-14 various views of an infusion pump in the form of a LVP 200 are shown. Both syringe pump 100 and LVP 200 make use of field replaceable unit (FRU) designs including a plurality of individual FRUs that enable pump components to be readily upgraded or replaced. Some FRUs are common to both syringe pump 100 and LVP 200. “Syringe pumps” generally include pumps for acting on a pre-filled infusate syringe that is mechanically driven under microprocessor control to deliver a prescribed amount or dose of the infusate at a controlled rate to a patient through an infusion line fluidly connected to the syringe. Syringe pumps typically include a motor that rotates a leadscrew or adjustment mechanism, for example. The leadscrew or adjustment mechanism, in turn, activates a syringe plunger driver of the syringe pump which in turn pushes forwardly against a plunger within a barrel of the syringe. Pushing the plunger forward then forces a dose of the infusate outwardly from the syringe, into the infusion line, and to the patient as aforedescribed. As used throughout this disclosure, the term “syringe pump” is intended to generally pertain to any medical infusion pump or device which acts on a syringe to controllably force fluid outwardly therefrom.


“LVPs” can take on various forms, but are typically infusion pumps coupled to one or more reservoirs configured to hold or store a relatively large amount of infusate or infusates, such as a cassette, IV bag, or other self-contained source. As used throughout this disclosure, the term “LVP” is intended to generally pertain to any medical infusion pump or device capable of large volume infusion to a patient.


Syringe Pump


Referring first to FIGS. 1-6, syringe pump 100 generally includes a user interface 110, housing 112, syringe plunger driver assembly 114, and syringe receptacle 116. Various other features of the syringe pump 100, including some that are internal or partially or fully obscured by the housing 112, will be later described with reference to the system diagram of FIG. 7.


As seen in FIG. 1, user interface 110 generally includes a display screen 118 and a keypad 120. Display screen 118 can be a rectangular, color LCD screen, and can be a touchscreen in certain embodiments. Display screen 118 can be any type of GUI display for use in controlling the syringe pump 100. In some embodiments, the display screen 118 can be configured to permit display of four lines of text, up to thirty characters long each. Accordingly, this size of display screen 118 advantageously enables viewing information such as, for example, drug names of significant length.


In some embodiments, certain commands or instructions are not controlled by a touchscreen, such as a display screen 118 and, instead, are controlled by a keypad 120. Keypad 120 is located adjacent to the display screen 118 and presents a variety of buttons and indicator lights. In some embodiments, push buttons requiring physical mechanical actuation are used on the keypad 120 for certain user commands, including: on/off power; audible alarm mute; start infusion, and stop infusion. Additional or fewer buttons on keypad 120 are contemplated as well. Physical mechanical actuation buttons, for primary or redundant purposes, provide increased safety and reliability to operators in cases where the touchscreen of a display 118 does not function properly, or is otherwise difficult to manipulate correctly. Having a user interface 110 including both a display screen 118 and a keypad 120, accordingly, provides the flexibility of a screen interface as well as the enhanced safety and reliability of physical control buttons.


The housing 112 generally forms a protective shell surrounding the internal components of the syringe pump 100. In some embodiments, the user interface 110 may be considered part of the housing 112. The housing 112 can be characterized as generally comprising a front housing assembly 122 and a rear housing assembly 124. Front housing assembly 122 generally surrounds the LCD display screen 118, keypad 120 and other components around the user interface 110. The front housing assembly 122 includes side panels 126 along the front portion of the syringe pump 100. A grouping of small holes can be located on one or both side panels 126 of the front housing 122 for audio speakers 128.


As illustrated in, for example, FIG. 4, rear housing assembly 124 generally includes a variety of contoured surfaces and shapes to protect the internal components of the syringe pump 100. The top portion 130 of the rear housing assembly 124 provides features defining a handle 132. The handle 132 is integrally formed into the outer surface of the rear housing assembly 124 and is partially defined by a central recess 134 in the top portion 130 of housing 112. The handle 132 provides a convenient structure for grasping, manipulating, and moving the syringe pump 100. The integrally formed nature of the handle 132 with the rest of the housing 112 provides advantages in medical settings due to an ability to be rather easily cleaned. In contrast, a non-integral handle and housing arrangement having a separate hinge or attachment features, could present a much more difficult component or assembly to clean.


As illustrated in, for example, FIG. 5, handle 132 is further part of a generally U-shaped retaining feature 136. Generally U-shaped retaining feature 136 can provide releasable interlocking engagement with other infusion pumps or related components. As illustrated in the perspective views of FIGS. 1 and 2, and particularly the top view of FIG. 5, the generally U-shaped retaining feature 136 can be seen. Generally U-shaped retaining feature 136 includes an upper lip portion 138 that extends inwardly around the central recess 134 located at the top portion 130 of the housing 112. The upper lip portion 138 extends around three sides of the recess 134, to form a general “U” shape when viewed from above. The section of the upper lip portion 138 in the middle of the general “U” shape partially comprises the handle 132. Beneath an overhang of this section of the upper lip portion 138 is a more deeply recessed space in which a user attempting to lift the syringe pump 100 can place his or her fingers and readily grasp the handle 132 from above.


In addition to the upper lip portion 138, the generally U-shaped retaining feature 136 further includes a set of receiving grooves 140 (as partially illustrated in, for example, FIGS. 2 and 4) underneath the upper lip portion 138, adjacent the rear face 142 of the rear housing assembly 124 at each end of the “U” shape. The receiving grooves 140 are slots which progressively narrow in structure and converge inwardly from the rear face 142 of the rear housing assembly 124. Forward of the receiving grooves 140 is a narrowed section 144 of housing, against which an inserted member can abut.


As illustrated in, for example, FIGS. 1 and 4, a latch 146 having a catch 148 is located on one side of the set of receiving grooves 140. This catch 148 is spring-loaded and able to click into place to hold a member loaded in the receiving grooves 140. Opposite these latch 146 and catch 148 members, on the side of the upper portion of the housing 112, is a further pump latch button 150. Pump latch button 150 can be pressed to unlock the latch 146 and catch 148 members such that a pump or component that is stacked and engaged to the handle 132 by receiving grooves 140, can be released and removed.


As shown in FIG. 2, rear housing assembly 124 also includes a downwardly extending and generally U-shaped projection 152 on a bottom portion 154 of pump 100. The generally U-shaped projection 152 is a protruding structure that can be placed in grooves (similar to receiving grooves 140 from other similar or identical pumps or devices). The generally U-shaped projection 152 is located on the bottom portion 154 of the rear housing assembly 124. As most clearly seen in the bottom view of the syringe pump 100 in FIG. 6, the generally U-shaped projection 152 includes a forward portion 156 and rearward portions 158.


The forward portion 156 of the generally U-shaped projection 152 is located in the middle of the “U” shape. The forward portion 156 forms a tightly curved “U” shape. The forward portion 156 provides a surface that can abut up against and mate with a corresponding surface of a pump or device, similar to that of narrowed section 144 of the generally U-shaped retaining feature 136 on the top portion 130 of the housing 112. The rearward portions 158 of the generally U-shaped projection 152 each provide segments of wider separation than the sides of the forward portion 156. The rearward portions 158 of the generally U-shaped projection 152 include a flange 160 with an outwardly extending lip 162 as illustrated in, for example, FIGS. 2 and 4. When taken together, the flange 160 and outwardly extending lip 162 provide a feature for sliding engagement. The generally U-shaped projection 152, accordingly, provides a structure that can be releaseably slid into and engaged below an upper lip portion 138 and within receiving grooves 140 of the generally U-shaped retaining feature 136. This type of coupling effectively provides so-called “tongue and groove” retention. Accordingly, the generally U-shaped retaining feature 136 and generally U-shaped projection 152 can enable multiple infusion pumps 100 to be stacked vertically on top of one another in an engaged tongue and groove arrangement when the pumps include those features compatibly.


In FIG. 2, other features that can be seen on the back, sides, and bottom of the housing 112 include: a battery door cover 164, power receptacle 166, Ethernet connector 168, USB port 170, and support structures or “mounting feet” 172 (that will be described in further detail). In general, battery door cover 164 provides a plate that can be removed to access a battery 174 (as depicted schematically in FIG. 7) located within the housing 112 of syringe pump 100. Battery door cover 164 is generally rectangular in shape but includes curved perimeter features to accommodate removable fasteners 176. Due to its ease of access and removal, battery 174 can be characterized as being a separate FRU for purposes of removal and replacement.


With reference again to, for example, FIGS. 2 and 4, power receptacle 166 is located in the back of the rear housing assembly 124 of the syringe pump 100. Power receptacle 166 may interface directly with a power cord, or alternatively, with a power connector contained on a pump rack. In the case of connection to a power cord, the power receptacle 166 provides a mechanical lock and retaining feature that prevents the power cord from being unintentionally pulled from operative engagement with the syringe pump 100. This can be useful to prevent power loss in an event of a slightly or unintentionally pulled or bumped power cord. The power receptacle 166 also has a tapered bevel structure which helps to accommodate interfacing with a power connector on a rack where the user typically has limited visibility for ensuring alignment.


Male and female connector portions can be keyed or otherwise restricted or controlled in orientation such that interlocking of the male and female components can only be made in a specified orientation. This can be advantageous in assisting proper alignment of pins, e.g., (+) to (+), and (−) to (−). The power cord connector can be keyed such that it cannot be connected in an improper orientation. In particular, the power cord connector can be a “right angle” connector, in some embodiments, yielding a low profile to decrease possible entanglements.


An Ethernet connector 168 is located on the side of housing 112 (in this example, near a back lower portion of the syringe pump 100). This location provides convenient access to other pumps, racks or communication devices that utilize Ethernet for data transfer. Ethernet connector 168 can be “ingress-protection” (or “IPX”) rated and does not require a cover. Similarly, USB port 170 is located on a side of housing 112 (in this example, near speaker 128). USB port 170 can have a cover and can be a so-called “on-the-go” connector for use with a variety of peripheral devices and applications.


Also designed to provide the stackable and user friendly design of syringe pump 100 are a set of support structures or mounting feet 172. In this example of pump 100, mounting feet 172 include two front mounting feet 172a and two rear mounting feet 172b. Front mounting feet 172a are extensions of the sides of housing 112 and rear mounting feet 172b are components that act to raise a back side of the housing 112. Rear mounting feet 172b provide clearance to the bottom portion 154 of the housing 112, such that the generally U-shaped projection 152 can extend downwardly without interfering with or causing disruption to physical stability of the pump 100. Similarly, in general, the mounting feet 172 are positioned so that stacked infusion pumps will not interfere with one another.


Also shown in FIGS. 1-6, is a syringe receptacle 116 and syringe plunger driver assembly 114. Syringe receptacle 116 includes an elongate cavity extending across the front of the syringe pump 100. Syringe receptacle 116 is located directly below the display screen 118 of the user interface 110. Location of the syringe receptacle 116 below the user interface 110 is advantageous in a number of respects. A syringe receptacle location below the user interface 110 aids in preventing leakages, fluid drips, or other unwanted contaminants from interfering with the display 118, keypad 120 or other potentially damageable electronic and mechanical features. In this location, the syringe receptacle 116 is somewhat spatially isolated from the remainder of the syringe pump 100 in the event of damages from syringe loading, unloading, or manipulation.


Syringe receptacle 116 contains a syringe ledge 178 on which a syringe can be operatively positioned. Syringe receptacle 116 effectively provides a cavity in the syringe pump 100 that remains open to the front of the pump 100 such that a loaded syringe is readily and substantially visible. Since the display screen 118 is located above the syringe receptacle 116, the screen 118 is generally not visually obstructed by presence of a syringe in pump 100. This non-overlapping and non-visually obscuring alignment of the receptacle and the screen simultaneously provides good visibility of both the syringe and display screen 118 in operation of pump 100.


Syringe receptacle 116 further includes an infusion line retention passage 180 (or tube guide) at one end, located opposite the end adjacent the syringe plunger driver assembly 114. The retention passage 180 provides a narrow segment in which an infusion line can pass. Specifically, retention passage 180 provides structural features which an infusion line can be looped against or around. The retention passage 180, accordingly, provides resistance from an infusion line being unintentionally pulled away from the syringe pump 100. Such pulling of the infusion line will meet resistance from the retention passage 180, rather than at the point where the infusion line is connected to a syringe located within the syringe receptacle 116.


As illustrated in, for example, FIGS. 1 and 3, syringe plunger driver assembly 114 is substantially located at an end of the syringe receptacle 116. Plunger driver assembly 114 includes a plunger driver 182, bumper 184, trigger 186, and flipper 188, among other components. The plunger driver assembly 114 is responsible for controlling delivery of a prescribed amount or dose of an infusate from a syringe in the pump 100 to a patient by mechanically depressing a plunger in the syringe to deliver the infusate at a controlled rate through an infusion line fluidly connected to the syringe. More specifically, a motor 190 rotates a leadscrew which, in turn, causes the plunger driver 182 that is operatively coupled to the leadscrew to move in a direction of the syringe receptacle 116. This movement then pushes the plunger within a barrel of the syringe located within the receptacle 116. Pushing the syringe plunger forward acts to force a dose of infusate in the syringe outwardly from the syringe, into an infusion line, and ultimately to a patient.


In the illustrated example of pump 100, bumper 184 of the plunger driver assembly 114 can be a generally rounded, end portion of plunger driver assembly 114 opposite the syringe receptacle 116. The bumper 184 is generally larger in diameter than the central portion of the plunger driver 182 and is made of a durable material that is relatively easy and ergonomic to grip. The bumper 184 is made for aiding in one-handed manipulation of the plunger driver assembly 114. Additionally, the “padded” construction of the bumper 184 provides some resistance to unintended impacts. Accordingly, based on its size and material, the plunger driver 182 is designed to help absorb any unintentional impacts on the plunger driver assembly 114, in an event of, for example, a dropped or mishandled syringe pump 100.


The trigger 186 is positioned at the back side of the plunger driver assembly 114. Trigger 186 is spring-loaded and acts to unlock the plunger driver assembly 114 from a locked state, such that the plunger driver assembly 114 can then relatively freely slide laterally when the trigger 186 is depressed. As depicted in, for example, FIG. 3, flipper 188 is located between the syringe receptacle 116 and the main plunger driver section 182 of the plunger driver assembly 114. The flipper 188 is generally a curved arm which extends over a distal thumb-press portion of a plunger in a syringe to help to removably secure the syringe in pump 100. Also in the proximity of the plunger driver assembly 114 is a barrel clamp lever 192 located under the keypad 120 of the user interface 110. Barrel clamp lever 192 may be manipulated to further engage or disengage retaining members from around the barrel of a syringe being removably secured in pump 100.


In general, the bumper 184, trigger 186, flipper 188, and barrel clamp lever 192 are used in loading and unloading operations of syringes into or out of the syringe receptacle 116. In the case of loading operations of syringes into the syringe pump 100, an initial step is to extend the plunger driver assembly 114 outwardly, away from the syringe receptacle 116. In order to accomplish this, a user can manipulate and engage the bumper 184 on the end of the plunger driver assembly 114 using the palm of his/her hand and depress the trigger 186 on the rear side of the plunger driver assembly 114 with his/her fingers of that same hand. Depressing the trigger 188 releases the plunger driver 182 from its locked position and allows the plunger driver 182 to slide outwardly and away from receptacle 116. Accordingly, the plunger driver 182 is initially slid to a desired distance appropriate for the syringe barrel of the syringe. Next, the syringe is placed into the syringe receptacle 116 such that the end of the syringe barrel abuts the interior surface of the plunger driver assembly 114 location, opposite the bumper 184. An infusion line connected to the syringe is threaded through the retention passage 180 at the end of the syringe receptacle 116 located opposite the plunger driver assembly 114. The flipper 188 rotates to descend over the thumb-press of the plunger in the syringe barrel and the barrel clamp lever 192 is manipulated so that the syringe barrel is further held in place. The user can then manipulate the user interface 110 to control the syringe pump 100 in the desired manner.



FIG. 7 depicts an example of a general system diagram of the syringe pump 100, including some components that are partially or fully obscured by the housing 112. Referring also to FIGS. 1-6, the system diagram of FIG. 7 shows a diagram of a syringe pump 100, including user interface 110, controller 194, motor 190, drive components (drivetrain) 196, power receptacle 166, battery 174, electrical circuitry 198, Ethernet connector 168, USB input port 170, speakers 128, and plunger driver head sensors 199.


As discussed above, the user interface 110 serves as a source of data input for the syringe pump 110 from, for example, a medical practitioner or pump programmer. Although not specifically illustrated in FIG. 7, it is to be appreciated and understood that user interface 110 may include a touchscreen display 118, keypad 120 or a combination of these or other user interface technologies.


In this example, controller 194 is connected to the user interface and is responsible for ensuring that the pump 100 is controlled in the desired manner. Controller 194 is located in the housing 212 and controls operation of the motor 190 and drive components 196. Controller 194 may include one or more processors. Controller 194 may further include memory in some embodiments.


Motor 190 is connected to the controller 194 and syringe pump components generally. Motor 190 may be included in the plunger driver assembly 114 in some embodiments. Motor 190 is the primary means for directing the drivetrain 196 (or drive components) to effect movement of the plunger driver assembly 114. Drivetrain 196 may be a set of drive components that are at least partially located in the housing 112 which are responsible for mechanically directing infusion of fluid from a syringe that has been operatively installed in pump 100.


The syringe pump system further includes either line power via a cord connected to the power receptacle 166 or via a connector in a rack that connects to the power receptacle 166. Battery 174 provides another alternate source of power to the infusion pump 100. In an embodiment, battery 174 is fully enclosed in the housing 112 beneath the rear battery panel 164.


Various electrical components and electrical circuitry 198 are located within the housing 112 that are required for relaying or carrying out commands to the controller 194 or within the system. Various outside devices may be connected to the syringe pump 100 as well through inputs, such as an Ethernet connector 168 or USB input port 170.


The speakers 128 are equipped to provide a full range of audio output including commands, alerts, and informative communications. Plunger driver head sensors 199 and other sensors are part of the system as well. Plunger driver sensors 199 can, for example, make various measurements for tasks such as characterizing syringes, detecting occlusions, and determining plunger position. Controller 194 utilizes information gained from these sensors 199 and other components to assist in communications and decision-making in set-up and operation of pump 100.


LVP


Referring to FIGS. 8-13, an example of a LVP 200 is shown. LVP 200 generally includes a user interface 210, housing 212, and assembly receptacle 213. Various other features of the LVP 200, including some that are internal or partially or fully obscured by the housing 212, will be later described with reference to the LVP system diagram of FIG. 14.


In general, significant portions of LVP 200 in FIGS. 8-14 and the syringe pump 100 described above and in FIGS. 1-7 are similar or identical. Accordingly, discussions of components having reference numerals in the “100's” in FIGS. 1-7 should generally be deemed to correspond to and apply to the similar components having corresponding reference numerals in the “200's” in FIGS. 8-14, unless otherwise distinguished in the following discussion (for example, the discussion of keypad 120 in FIG. 1 applies to keypad 220 in FIG. 8 as well).


As seen in FIG. 8, user interface 210 generally includes a display screen 218 and a keypad 220. User interface 210, display screen 218 and keypad 220 respectively correspond to user interface 110, display screen 118 and keypad 120. A variety of configurations for touchscreen and mechanical buttons are contemplated.


The housing 212 corresponds to housing 112 and generally forms a protective shell surrounding the internal components of the LVP 200. In some embodiments, the user interface 210 may be considered part of the housing 212. The housing 212 can be characterized as generally comprising a front housing assembly 222 and a rear housing assembly 224.


Front housing assembly 222 generally surrounds the LCD display screen 218, keypad 220 and other components in the proximity of the user interface 210. Front housing assembly 222 is largely the same as the front housing assembly 122 of the syringe pump 100, however, the shape of the front housing assembly 222 around the assembly receptacle 213 and user interface 210 is shaped differently so that the features of the assembly receptacle 213 are appropriately accommodated.


Rear housing assembly 224 is generally consistent with rear housing assembly 124. Features on the rear housing assembly 224 include a handle 232, central recess 234, and a generally U-shaped retaining feature 236 defined in the top portion 230 of the housing 212. These features are analogous to those discussed with respect to the syringe pump 100 as well. The generally U-shaped upper lip portion 238 surrounding central recess 234 and receiving grooves 240 extend inwardly from rear face 242. This arrangement provides features for receiving a projection of another pump and gripping the U-shaped retaining features 236 as a handle 232.


As in the syringe pump 100, the handle 232 of the LVP 200 is integrated with housing 212 and is part of the generally U-shaped retaining feature 236. Similarly, generally U-shaped projection 252 is located on the bottom portion 254 of the housing 212 and is analogous to the generally U-shaped projection of the syringe pump 100. As in the configuration of syringe pump 100, U-shaped projection 252 is comprised of a forward portion 256 and rearward portions 258. The rearward portions 258 include a flange 260 and outwardly extending lip 262 which are sized to engage with retaining grooves 240 of another pump. Accordingly, LVPs 200 and syringe pumps 100 can be readily stacked and coupled with one another.


With particular reference to FIG. 9, features that can be seen on the rear face 224, sides 226, and bottom portion 254 of the housing 212 include: a battery door cover 264, power receptacle 266, Ethernet connector 268, USB port 270, and mounting feet 272. Each of these components correspond to analogous parts of syringe pump 100.


Also shown in FIGS. 8-13, is an assembly receptacle 213. Assembly receptacle 213 includes an elongate cavity extending across the front of the LVP 200. Assembly receptacle 213 is located directly below the display screen 218 of the user interface 210. Assembly receptacle 213 contains passages 251 out each end as well as a central passage through which an infusion line for carrying out patient infusion can extend through and be acted on. Further, assembly receptacle 213 includes features permitting a tubing frame assembly of the patient infusion line to be removably mounted and acted on by fingers of a peristaltic pumping mechanism.


The interior features of the assembly receptacle 213 are largely obstructed from view in FIGS. 8-13 by a hinged door 253. Door 253 further contains a centrally located latch lever 255 for securing the door 253 in the closed position depicted. When the LVP 200 is in use, the door 253 is first placed in an open orientation. A tubing frame assembly coupled to the infusion line is received by the assembly receptacle 213. This loading of the tubing frame assembly can be done via one-handed motion. Next, the door 253 can be rotated closed about hinges 257 (as illustrated in, for example, FIG. 13) at the bottom front edge 259 of the LVP 200. Door latch lever 255 can then be moved from an unlatched position to a latched position as shown in FIGS. 8-13. For purposes of this description, the operational details of the LVP components in the assembly receptacle 213 are not specifically discussed.


As depicted in, for example, FIG. 10, assembly receptacle 213 includes infusion line retention passages 251 at both ends. The retention passages 251 (or tube guides) provide a narrow segments in which an infusion line can pass. At any suitable time, which may be before or after door 253 is closed, upstream and downstream tubing (not illustrated in FIGS. 8-13) can be manually pressed into retention passages 251.


Various assemblies and methods for infusion system administration sets such as, for example, an aforementioned tubing frame assembly that can be removably secured in receptacle 213, are discussed in PCT App No. PCT/US2017/037929 of Adams et al., titled “Assemblies and Methods for Infusion Pump System Administration Sets”, and published as WO 2017/218927 A1, which is hereby incorporated by reference.



FIG. 14 depicts an example of a general system diagram of the LVP 200, including some components that are partially or fully obscured by the housing 212. The system diagram shows a diagram of a LVP 200, including user interface 210, controller 294, motor 290, drive components 296, power receptacle 266, battery 274, electrical circuitry 298, Ethernet connector 268, USB input port 270, speakers 228, and assembly receptacle sensors 299.


As discussed above, the user interface 210 serves as a source of data input for the syringe LVP 200 from, for example, a medical clinician or pump programmer. Although not specifically illustrated in FIG. 14, it is to be appreciated and understood that user interface 210 may include a touchscreen display 218, keypad 220 or a combination of these or other user interface technologies.


In this example, controller 294 is connected to the user interface and is responsible for ensuring that the pump is controlled in the desired manner. Controller 294 may include one or more processors. Controller 294 may further include memory in some embodiments.


Motor 290 is connected to the controller and LVP components generally. Motor 290 can be a stepper motor in some embodiments. In this example, motor 290 is the primary means for directing the drive components 296 to effect movement of the fingers in the assembly receptacle 213 (as illustrated in, for example, FIG. 8) against the tubing.


The example of the LVP system in FIG. 14 further includes either line power, via a cord connected to the power receptacle 266 or, via a connection member in a rack that connects to the power receptacle. Battery 274 is another alternate source of power to the LVP 200. The battery 274 can be fully enclosed in the housing 212 beneath the rear battery door cover 264 (as depicted in FIG. 9, for example).


Referring again to FIG. 14, various electrical components and electrical circuitry 298 are located within the housing 212 for relaying or carrying out commands to the controller 294 or within the system. Various outside devices may be connected to the LVP 200 as well through inputs, such as an Ethernet connector 268 or USB port 270.


The speakers 228 are equipped to provide a full range of audio output including commands, alerts, and informative communications. Assembly receptacle sensors 299 and other sensors can be part of the system as well. Assembly receptacle sensors 299, for example, can make various measurements for tasks such as sensing information about the particular tubing frame assembly. This can include sensing the route of infusion for which a particular tubing frame assembly is used. Sensors can be optical sensors, RFID readers, etc. Controller 294 can utilize information gained from these sensors 299 and other components to assist in communications and decision-making in set-up and operation of pump 100.


As noted above, syringe pump 100 and LVP 200 make use of a plurality of individual FRUs that enable pump components to be readily upgraded or replaced. FRU components provide ease of pump manufacture as well as simplified maintenance and replacement. Various FRU configurations contemplated herein can be interchangeable and common to both types of infusion pumps discussed. In general, FRUs can be categorized into three groups: wear components (components that will need to be replaced due to breakage or end-of-life, etc.); faster moving technology (communications, WiFi, Bluetooth®, USB, the display); and functionality upgrades (syringe security, PCA, TCI, etc.). FRUs can be interchanged between categories at times as well by virtue of these being modules with interfaces. For example, to improve the performance of a wear component, a user might upgrade the functionality. E.g., a pumping mechanism that does not meet breakage or wear component requirements could be “upgraded” by higher performance or added feature FRUs—ones that have the desired capabilities to essentially replace the previous wear component. In a pump, a higher-performance FRU can be recognized by the pump and the pump's operating parameters can be adjusted automatically to be compatible with the newly installed FRU. Additionally, the pump would have knowledge of its configuration and therefore it would essentially report back its own configuration for logging into, e.g., a DMR (Device Master Record).


In one example, both syringe pump 100 and LVP 200 have a common FRU comprising the rear portion of the pumps. This common FRU includes significant portions of the housing and rear components for both types of infusion pumps discussed. This component is shown as FRU 101 in FIG. 15. and can be understood from corresponding reference numerals and parts of FIGS. 1-14 as well. Specifically, FRU 101 largely includes rear housing assembly 124 or 224 for an infusion pump. The rear housing 124 or 224 includes a top portion 130 or 230 and part of bottom portion 154 or 254. The top portion 130 or 230 has an integrally formed handle structure 132 or 232 and a set of receiving grooves 140 or 240. The bottom portion 154 or 254 has a projection 152 or 252 for releasable coupling with receiving grooves (such as 140 or 240) in another rear housing. The rear housing 124 or 224 can include a power receptacle 166 or 266 and an Ethernet connector 168 or 268. The rear housing 124 or 224 interchangeably couples with a set of infusion pump system components (such as a plunger driver assembly 114 and syringe receptacle 116 or LVP motor and drive components and assembly receptacle 213), a control system (such as controller 194 or 294), and a display of either a LVP or a syringe pump (such as display screen 118 or 218).


In some embodiments, FRUs can include components or groups of components of the pump. Examples of such FRUs can include: a rear housing assembly; an LVP front housing with motor, pump, display and keypad; a syringe front housing with display and keypad; a battery pack with gas gauge; a power supply; wireless components; a PCB BOARD assembly; a LVP door; a syringe drive; and a syringe plunger head.


In some embodiments, FRUs can include battery pack modules (additional, supplemental, or standby). Similarly, in some embodiments, FRU's can include battery charging or power modules (possibly incorporating or interfacing with portable solar, wind, or mechanical crank-type generators). Interfaces to off-the-shelf batteries for military use can be provided in some embodiments. In certain cases, a battery charging or power module can interface with one or more pumps that are “connected”. For example, a pump and a headless pump, in a stack could all interface with a battery charging or power module.


In some embodiments, FRUs can include alarm modules (both visual and/or audible). Specifically an alarm module can interface with one or more pumps that are “connected”. For example, a pump and a headless pump, in a stack could all interface with an alarm module.


In some embodiments, FRUs can include: PCA modules; syringe security devices (such as a lockbox); a communications module; or a user authentication module (such as one using biometric inputs, of fingerprints, voice, facial recognition, etc.) that can unlock an entire connected stack.


In some embodiments, FRUs of power and communication relate to alternatives to or proxies for a rack. In some embodiments, FRUs having Bluetooth® or Wifi are contemplated. In some embodiments, the FRUs can be in a daisy chain of communication (wired or wireless) and/or power. In some cases, FRUs include power selector or adapter modules. For example, modules for adaptation to local (unique) power sources or power sources that are commonly used for or in other devices (AC/DC power). In various embodiments, FRUs can be locked.


In other contemplated embodiments, the pumps themselves can be FRUs. For example, this can be the case in a collective pumping arrangement comprising a syringe pump, an LVP and a headless syringe. In some embodiments, an FRU can copy the programming of a device that has failed. See PCT App. No. PCT/US2017/042633 of Diez et al., titled “Cloning Medical Device Configurations”, and published as WO 2018/022355 A1, which is hereby incorporated by reference.


Referring to FIGS. 16A and 16B, infusion pump arrangements are shown which depict the racking and stacking capabilities of the pumps. Specifically, FIG. 16A depicts a pole mounted arrangement 300 in which a plurality of syringe pumps 100 are mounted on a movable rack 310. Rack 310 is designed to hold up to eight infusion pumps 100, as depicted, in some embodiments. Rack 310 has a wide wheeled base with legs 320 which aids in preventing the rack from tipping. Further, an IV pole 330, is attached via arms 340 extending from the side of the rack 310. The IV pole 330 is located above a leg 320 of the rack 310 so that the weight of any bag(s) of mounted fluid or infusate, such as an IV bag, will be supported and will not cause instability to the rack 310. In some embodiments, rack 310 can be further advantageous as it can provide an AC power supply, space management, and a consolidated Ethernet connection.


Rack 310 permits the individual installation and removal of infusion pumps, such as syringe pumps 100. This individualized mounting capability means that a suitable syringe pump 100 or other suitable infusion pump can be readily installed or removed from a group of such pumps. This flexibility is particularly advantageous for troubleshooting and reconfiguring groups of infusion pumps.


The vertically grouped arrangement of the racked arrangement 300 in FIG. 16A can be analogous to the stacked arrangement 400 of FIG. 16B as well. Specifically, in this example of FIG. 16B, syringe pumps 100 can be seen stacked directly above or below each other, vertically. This type of stacking may utilize a pole mount, in some embodiments, for example. When the top syringe pump 100 is secured in place, for example, a subsequent syringe pump 100 can be secured below it by attachment features integrated into the syringe pump housing 112 of both pumps. Specifically, and as aforedescribed, the generally U-shaped projection 152 on the bottom of the top syringe pump 100 permits the receiving grooves 140 of the generally U-shaped retaining feature 136 of the below syringe pump 100 to be slid over the outwardly extending lip 162. The U-shaped retaining feature 136 is slid until the forward portion 156 of the U-shaped projection 152 abuts underneath the upper lip portion 138 of the below syringe pump 100. A feature of this stacked arrangement of syringe pumps 100 is that each user interface display screen 118, as well as corresponding syringes 102, can be readily viewed at the same time. This permits a medical practitioner the ability to quickly see the status of all the syringe pumps at one glance, even if done from across a room.


Although FIGS. 16A and 16B show syringe pumps 100 in racked and stacked arrangements, other types of infusion pumps should be understood to be capable of being racked and stacked in this manner, as well, such as LVPs 200. Accordingly, racks and stacks of either all syringe pumps 100, all LVPs 200, or a mix of different kinds of pumps racked or stacked together are possible.


Referring to FIG. 17, a perspective view is shown of an infusion pump configuration 500 in which an external backup battery pack 501 is attached to a syringe pump 100. An external backup battery pack 501 may be used in cases where access to AC power is limited. For example, in more remote regions or in transport vehicles, having a group of battery power supplies can provide the flexibility needed to run infusion pumps in nearly any location for extended periods of time. The external backup battery pack 501 contemplated can have a cord which plugs into the power receptacle 166 in the back of the housing 112 to supply power to the syringe pump 100. The external backup battery pack 501 can also have a generally U-shaped projection of the battery pack 501 on its bottom surface similar to the generally U-shaped projections 152 and 252 on the bottom of the infusion pumps 100 and 200 described herein. Accordingly, this generally U-shaped projection is able to mate with the generally U-shaped retaining feature 136 or 236 on the top of the pump 100 or 200. This arrangement provides a secure and durable coupling for the pump 100 or 200 and its power supply. Moreover, once external backup battery pack 501 runs low on power, another similar unit can simply replace it and likewise attach to the top portion of the syringe pump 100.



FIG. 18 depicts an embodiment of an infusion pump configuration 600, including a set of infusion pumps including a LVP 200 coupled to a set of stacked, “headless” LVPs 611. In general, LVP 200 depicts an LVP similar to those described in FIGS. 8-14. This LVP 200 is shown in a stacked arrangement with other “headless” LVPs 611. These LVPs 611 are “headless” in the sense that they do not contain the user interface 210 of LVP 200 and are much more compact in size. These headless LVPs 611 are made possible when a stacked arrangement (or racked, if on a rack) is constructed and operatively coupled in communication which can rely on one user interface 210 to control pumping operations of a stacked or (racked) set of infusion pumps. Constructing such “headless” LVPs without including relatively more expensive user interface components on each pump can provide a significant cost savings to pump manufacturing. In an embodiment, “headless” pumps can communicate with each other via Bluetooth® or other wireless communication. “Headless” pumps can also be, additionally or alternatively, wired to each other and may communicate via USB or Ethernet ports, for example.


Headless LVPs 611 may each include a generally U-shaped retaining feature 236 on their top surfaces and a generally U-shaped projection 252 on the bottom surface similar to the ones described for the LVPs 200. Accordingly the pumps can be readily coupled with so-called “tongue-and-groove” arrangement similar to the arrangements 300 and 400 in FIGS. 16A and 16B. Further, “headless” pumps are not limited to LVPs. Syringe pumps 100 can also be provided as “headless” infusion pumps in which no user interface is contained on certain syringe pumps 100 in a pump stack or rack.


Other ease of use features are also contemplated by this disclosure. For example, in some embodiments, all pump components with which a user is intended to interface are specially color coded. In the case of the example of syringe pump 100 herein, each of the areas for user interaction are visually color-coded blue. Accordingly, the bumper 184, trigger 186, keypad 120, barrel clamp lever 192, USB port 170, Ethernet connector 168, catch 148 and pump latch button 150 would be colored blue. In the case of the LVP 200, the latch lever 255, keypad 220, USB port 270, Ethernet connector 268, catch 248 and pump latch button 250 would be colored blue.


Throughout this disclosure and figures, generally U-shaped retaining feature 136, generally U-shaped retaining feature 236, generally U-shaped projection 152, generally U-shaped projection 252, and other features described as “generally U-shaped” should be interpreted in a largely non-limiting manner and can also be alternatively and/or interchangeably referred to understood as simply being “U-shaped”. Although the components referenced are largely understood based on their depiction from a top or bottom perspective, the “U-shaped” and “generally U-shaped” terminology should be interpreted in a largely non-limiting way. For example, the description can be understood to include one continuous largely semicircular shape or a shape having a base with two side members extending therefrom. The term “U-shape” can include base and side components having rounded or squared intersections. The side components can be disposed in parallel, converging or diverging orientations. In some embodiments, a “generally U-shaped” component is broad enough to include side members that meet at a single base location to form a “V”. Other configurations are possible as well. Accordingly, corresponding claim terms should be interpreted in a corresponding, broadly construed manner.


Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the claimed subject matter. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the claimed subject matter.


Persons of ordinary skill in the relevant arts will recognize that the subject matter hereof may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the subject matter hereof may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the various embodiments can comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art. Moreover, elements described with respect to one embodiment can be implemented in other embodiments even when not described in such embodiments unless otherwise noted.


Although a dependent claim may refer in the claims to a specific combination with one or more other claims, other embodiments can also include a combination of the dependent claim with the subject matter of each other dependent claim or a combination of one or more features with other dependent or independent claims. Such combinations are proposed herein unless it is stated that a specific combination is not intended.


Any incorporation by reference of documents above is limited such that no subject matter is incorporated that is contrary to the explicit disclosure herein. Any incorporation by reference of documents above is further limited such that no claims included in the documents are incorporated by reference herein. Any incorporation by reference of documents above is yet further limited such that any definitions provided in the documents are not incorporated by reference herein unless expressly included herein.


For purposes of interpreting the claims, it is expressly intended that the provisions of 35 U.S.C. § 112(f) are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.

Claims
  • 1. An infusion pump, comprising: a housing enabling selective stacked attachment with other infusion pumps, the housing including: a front side;a rear side;a top portion comprising a generally U-shaped retaining feature having: an upper lip portion extending inwardly toward a central recess, the upper lip portion extending around the retaining feature;a handle formed in an outer surface of the housing and partially defined by the central recess;a narrowed section of housing; anda pair of receiving grooves oriented underneath the upper lip portion, each receiving groove extending between the narrowed section of the housing to the rear side;a bottom portion comprising a generally U-shaped projection having: a forward portion arranged in the middle of the generally U-shaped projection; anda pair of rearward portions each including a flange and an outwardly extending lip, each rearward portion configured to be slidingly inserted into a receiving groove and abut against a narrowed section of housing of a corresponding other infusion pump;a user interface providing a front side to the housing that receives commands regarding infusion pump operation;a motor and a set of drive components, at least partially located within the housing, that mechanically direct infusion of an infusate; anda controller located within the housing that controls operation of the motor and the set of drive components.
  • 2. The infusion pump of claim 1, wherein the infusion pump is a syringe pump.
  • 3. The infusion pump of claim 1, wherein the infusion pump is an LVP pump.
  • 4. The infusion pump of claim 1, wherein the user interface includes both a touchscreen and a keypad control.
  • 5. The infusion pump of claim 1, wherein the housing includes an external battery pack having a projection that removeably mates within the generally U-shaped retaining feature.
  • 6. A syringe pump, comprising: a syringe receptacle configured to receive a syringe of an infusate;a syringe plunger driver assembly located adjacent the syringe receptacle, that directs the infusate from the syringe to a patient based on movement against a plunger of the syringe;a housing coupled with the syringe receptacle, the housing including: a front side including a GUI display for controlling the syringe pump;a rear side;a top portion comprising a retaining feature having: an upper lip portion extending inwardly toward a central recess, the upper lip portion extending around the retaining feature;a handle formed in an outer surface of the housing and partially defined by the central recess;a narrowed section of housing; anda pair of receiving grooves oriented underneath the upper lip portion, each receiving groove extending between the narrowed section of the housing to the rear side; anda bottom portion comprising a projection having: a forward portion arranged in the middle of the projection; anda pair of rearward portions each including a flange and an outwardly extending lip, each rearward portion configured to be slidingly inserted into a receiving groove and abut against a narrowed section of housing of a corresponding other infusion pump,wherein each of the retaining feature and the projection are arranged within a boundary defined by the rear side and the GUI display on the front side,wherein the syringe receptacle is located on the front side of the housing vertically adjacent the GUI display in non-overlapping alignment, the housing configured such that both the syringe in the syringe receptacle and the entire GUI display are visible on the front side of the housing.
  • 7. The syringe pump of claim 6, wherein the syringe receptacle is located beneath the GUI display.
  • 8. The syringe pump of claim 6, wherein the GUI display is a touchscreen.
  • 9. The syringe pump of claim 6, wherein four lines of text are displayable on the GUI at the same time.
  • 10. The syringe pump of claim 6, wherein the syringe pump is configured for one-handed operation.
  • 11. An infusion pump assembly, comprising: a first infusion pump having a housing and a user interface with a display screen, the housing including: a front side; anda bottom portion comprising a generally U-shaped projection having: a forward portion arranged in the middle of the generally U-shaped projection; anda pair of rearward portions each including a flange and an outwardly extending lip; anda headless infusion pump having no display screen, the headless infusion pump including: a rear side;a top portion comprising a generally U-shaped retaining feature having: an upper lip portion extending inwardly toward a central recess, the upper lip portion extending around the retaining feature;a handle formed in an outer surface of the housing and partially defined by the central recess;a narrowed section of housing; anda pair of receiving grooves oriented underneath the upper lip portion, each receiving groove extending between the narrowed section of the housing to the rear side;wherein the headless infusion pump is configured to be releasably slidingly coupled to the housing of the first infusion pump by tongue and groove attachment, each rearward portion of the first infusion pump configured to be slidingly inserted into each receiving groove and abut against the narrowed section of housing of the headless infusion pump.
  • 12. The infusion pump assembly of claim 11, further including a plurality of headless infusion pumps.
  • 13. The infusion pump assembly of claim 12, wherein the plurality of headless infusion pumps contain both a LVP and a syringe pump.
  • 14. The infusion pump assembly of claim 12, wherein the plurality of headless infusion pumps communicate with one another via Bluetooth.
  • 15. The infusion pump assembly of claim 11, wherein the first infusion pump is a syringe pump.
  • 16. The infusion pump assembly of claim 11, wherein the first infusion pump is a LVP.
  • 17. A field replaceable unit for infusion pumps, comprising: a rear housing for an infusion pump including: a rear side;a top portion comprising a retention feature having: an upper lip portion extending inwardly toward a central recess, the upper lip portion extending around the retaining feature;a handle formed in an outer surface of the housing and partially defined by the central recess;a narrowed section of housing; anda set of grooves oriented underneath the upper lip portion, each receiving groove extending between the narrowed section of the housing to the rear side;a bottom portion comprising a projection having: a pair of rearward portions each including a flange and an outwardly extending lip, each rearward portion configured to be slidingly inserted into a receiving groove and abut against a narrowed section of a corresponding other field replaceable unit for infusion pump; andwherein the rear housing interchangeably couples with a set of medication delivery components, a control system, and a display of different types of infusion pumps, including a LVP and a syringe pump.
  • 18. The field replaceable unit for infusion pumps of claim 17, wherein the rear housing interchangeably couples with a set of medication delivery components, a control system, and a display of a patient-controlled analgesia pump.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims priority to U.S. Provisional Patent Application No. 62/534,407, filed on Jul. 19, 2017, which is hereby fully incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2018/042907 7/19/2018 WO
Publishing Document Publishing Date Country Kind
WO2019/018658 1/24/2019 WO A
US Referenced Citations (358)
Number Name Date Kind
3778195 Bamberg Dec 1973 A
4537561 Xanthopoulos Aug 1985 A
4620736 Shanks Nov 1986 A
4749109 Kamen Jun 1988 A
4756706 Kerns Jul 1988 A
4978335 Arthur, III Dec 1990 A
5034004 Crankshaw Jul 1991 A
D328952 Arioka Aug 1992 S
5236416 McDaniel et al. Aug 1993 A
5254096 Rondelet et al. Oct 1993 A
D344684 Metz et al. Mar 1994 S
5295966 Stem et al. Mar 1994 A
D348101 Poli et al. Jun 1994 S
5364364 Kasvikis et al. Nov 1994 A
5425173 Moss et al. Jun 1995 A
D360259 Ijiri et al. Jul 1995 S
5431509 Anderson et al. Jul 1995 A
5452807 Foster et al. Sep 1995 A
D363468 Mieki et al. Oct 1995 S
5478211 Dominiak et al. Dec 1995 A
D367527 Marston et al. Feb 1996 S
D367528 Marston et al. Feb 1996 S
D371194 Marston et al. Jun 1996 S
5533981 Mandro et al. Jul 1996 A
5545140 Conero et al. Aug 1996 A
5551850 Williamson et al. Sep 1996 A
5601420 Warner et al. Feb 1997 A
5620312 Hyman et al. Apr 1997 A
5647491 Foster et al. Jul 1997 A
5647854 Olsen et al. Jul 1997 A
D390654 Alsberg et al. Feb 1998 S
5782805 Meinzer et al. Jul 1998 A
5807322 Lindsey et al. Sep 1998 A
5814009 Wheatman Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5823746 Johnson Oct 1998 A
5840058 Ammann et al. Nov 1998 A
5879360 Crankshaw Mar 1999 A
5901150 Jhuboo et al. May 1999 A
5904668 Hyman et al. May 1999 A
5954485 Johnson et al. Sep 1999 A
5954527 Jhuboo et al. Sep 1999 A
6019745 Gray Feb 2000 A
D435021 Davis et al. Dec 2000 S
6187400 Woo et al. Feb 2001 B1
6195887 Danby et al. Mar 2001 B1
6203528 Deckert et al. Mar 2001 B1
6213723 Danby et al. Apr 2001 B1
6213739 Phallen et al. Apr 2001 B1
6231320 Lawless et al. May 2001 B1
6312227 Davis Nov 2001 B1
D455489 Beck et al. Apr 2002 S
6407335 Franklin-Lees et al. Jun 2002 B1
6500151 Cobb et al. Dec 2002 B1
6519569 White et al. Feb 2003 B1
6551277 Ford Apr 2003 B1
D474837 Gillespie, Jr. et al. May 2003 S
6575936 Kojima et al. Jun 2003 B1
6592551 Cobb Jul 2003 B1
6593528 Franklin-Lees et al. Jul 2003 B2
6656148 Das et al. Dec 2003 B2
6659976 Beck et al. Dec 2003 B2
6722865 Domroese Apr 2004 B2
6742992 Davis Jun 2004 B2
6743202 Hirschman et al. Jun 2004 B2
D501924 Cise et al. Feb 2005 S
6852094 Beck et al. Feb 2005 B2
D504507 Ziegler et al. Apr 2005 S
D507647 Beck et al. Jul 2005 S
6966895 Tribe Nov 2005 B2
D523553 Beck et al. Jun 2006 S
7121815 Knuth et al. Oct 2006 B2
7160087 Fathallah et al. Jan 2007 B2
7161488 Frasch Jan 2007 B2
D536783 Cise et al. Feb 2007 S
7211726 Bally et al. May 2007 B2
7214038 Saxer et al. May 2007 B2
7227081 Bally et al. Jun 2007 B2
7236936 White et al. Jun 2007 B2
7273359 Blight et al. Sep 2007 B2
7278615 Schubert et al. Oct 2007 B2
7356382 Vanderveen Apr 2008 B2
7422570 Gerlach et al. Sep 2008 B2
D586463 Evans et al. Feb 2009 S
D586468 Petersen Feb 2009 S
7503808 O'Shea Mar 2009 B1
7553291 Duffy et al. Jun 2009 B2
7556616 Fathallah et al. Jul 2009 B2
7632079 Hershberger et al. Dec 2009 B2
7635349 Tribe et al. Dec 2009 B2
D626647 Amborn et al. Nov 2010 S
7859473 Gibson Dec 2010 B2
7884735 Newkirk Feb 2011 B2
7896572 Fathallah et al. Mar 2011 B2
7934912 Voltenburg, Jr. et al. May 2011 B2
7963797 Knappe Jun 2011 B2
7967773 Amborn et al. Jun 2011 B2
D642677 Boaz Aug 2011 S
8062008 Voltenburg, Jr. et al. Nov 2011 B2
8083503 Voltenburg, Jr. et al. Dec 2011 B2
8109906 Smisson, III et al. Feb 2012 B2
D655810 Amborn et al. Mar 2012 S
8161810 Cadieux et al. Apr 2012 B2
8182461 Pope et al. May 2012 B2
D669096 Katsura Oct 2012 S
8337168 Rotem et al. Dec 2012 B2
8388582 Eubanks et al. Mar 2013 B2
8388598 Steinkogler Mar 2013 B2
D679379 Katsura Apr 2013 S
8430849 Smith et al. Apr 2013 B2
8459968 Juretich et al. Jun 2013 B2
8496613 Zhou Jul 2013 B2
8499108 Edwards et al. Jul 2013 B2
D691259 Estes et al. Oct 2013 S
8545458 Gagliardoni et al. Oct 2013 B2
8551056 Gagliardoni et al. Oct 2013 B2
8551057 Gagliardoni et al. Oct 2013 B2
8662458 Henault et al. Mar 2014 B2
8715224 Kamen et al. May 2014 B2
8777590 Moy et al. Jul 2014 B2
8834443 Yeung Sep 2014 B2
8859972 Cummings et al. Oct 2014 B2
8876793 Ledford et al. Nov 2014 B2
8911403 Flachbart et al. Dec 2014 B2
8974415 Robert et al. Mar 2015 B2
8986252 Cummings et al. Mar 2015 B2
9008803 Blomquist Apr 2015 B2
9011379 Hariharesan et al. Apr 2015 B2
D730514 Boaz et al. May 2015 S
9050411 Kelly et al. Jun 2015 B2
9056166 Zhu Jun 2015 B2
9072540 Jamagin et al. Jul 2015 B2
9084848 Schiltges et al. Jul 2015 B2
9101712 Denis et al. Aug 2015 B2
9114213 Murakami et al. Aug 2015 B2
9115708 van der Merwe et al. Aug 2015 B2
9115709 Gray et al. Aug 2015 B2
9132227 Bryant, Jr. et al. Sep 2015 B2
9132234 Estes et al. Sep 2015 B2
9138526 Ware et al. Sep 2015 B2
9155825 Kelly et al. Oct 2015 B2
9155835 Watanabe et al. Oct 2015 B2
9162027 Kamen et al. Oct 2015 B2
9168333 Kelly et al. Oct 2015 B2
9183603 Borges et al. Nov 2015 B2
9192711 Barnes Nov 2015 B2
9192714 Kaufmann et al. Nov 2015 B2
9205188 Lanigan et al. Dec 2015 B2
9238101 Hariharesan et al. Jan 2016 B2
9242035 Karoor Jan 2016 B2
9248225 Demers et al. Feb 2016 B2
9248230 Geipel et al. Feb 2016 B2
9265879 Gray Feb 2016 B2
9265890 Chattaraj et al. Feb 2016 B2
9272089 Jacobson et al. Mar 2016 B2
9272129 Howlett et al. Mar 2016 B2
9278174 Gray Mar 2016 B2
9283312 Childers et al. Mar 2016 B2
9283370 Travis et al. Mar 2016 B2
9289552 Gerlach et al. Mar 2016 B2
9295778 Kamen et al. Mar 2016 B2
9302039 Kelly et al. Apr 2016 B2
9314566 Wenger et al. Apr 2016 B2
9320849 Smith et al. Apr 2016 B2
9320858 Grimm et al. Apr 2016 B2
9339603 Gray et al. May 2016 B2
9352083 Heitmeiter et al. May 2016 B2
9358332 McGill et al. Jun 2016 B2
9359885 Slepicka et al. Jun 2016 B2
9377513 Lindegger Jun 2016 B2
9378334 Lee et al. Jun 2016 B2
D761741 Santiago et al. Jul 2016 S
9387286 Kelly et al. Jul 2016 B2
9415150 Hogard et al. Aug 2016 B2
9421313 Kelly et al. Aug 2016 B2
9427520 Batch et al. Aug 2016 B2
9427521 Pope et al. Aug 2016 B2
D765832 Hochman et al. Sep 2016 S
D766204 Takahata Sep 2016 S
9446186 Estes Sep 2016 B2
9446188 Grant et al. Sep 2016 B2
9468713 Hoenninger, III Oct 2016 B2
9488167 Gray et al. Nov 2016 B2
9498573 Smith et al. Nov 2016 B2
9526830 Kamen et al. Dec 2016 B2
9530087 Borges et al. Dec 2016 B2
D777119 Lin et al. Jan 2017 S
9539383 Kohlbrecher Jan 2017 B2
9545475 Borges et al. Jan 2017 B2
9550020 Kelly et al. Jan 2017 B2
9554967 Moi et al. Jan 2017 B2
9561324 Estes Feb 2017 B2
9572919 Kelly et al. Feb 2017 B2
9572923 Howard et al. Feb 2017 B2
9586003 Lee et al. Mar 2017 B2
9592338 Pearson et al. Mar 2017 B2
9593679 Gray et al. Mar 2017 B2
9616170 Nakanishi et al. Apr 2017 B2
9623180 Iio et al. Apr 2017 B2
9623198 Kamen et al. Apr 2017 B2
D787504 Hillman et al. May 2017 S
9642965 Marshall et al. May 2017 B2
9649431 Gray et al. May 2017 B2
9649433 Lanier, Jr. et al. May 2017 B2
9656052 Slepicka et al. May 2017 B2
9662437 Moosai May 2017 B2
9662438 Kamen et al. May 2017 B2
9669161 Bryant, Jr. et al. Jun 2017 B2
9682191 Zhu Jun 2017 B2
9682199 Walsh et al. Jun 2017 B2
9690909 Stewart et al. Jun 2017 B2
D791937 Schoenig et al. Jul 2017 S
9707336 Dang et al. Jul 2017 B2
D793346 Folk et al. Aug 2017 S
9724456 Muller et al. Aug 2017 B2
9724458 Grant et al. Aug 2017 B2
9731072 Estes Aug 2017 B2
9744304 Swift et al. Aug 2017 B2
9753015 Bardina et al. Sep 2017 B2
D800717 Hillman et al. Oct 2017 S
D801519 Sabin et al. Oct 2017 S
9775964 Eubanks et al. Oct 2017 B2
9789247 Kamen et al. Oct 2017 B2
9789251 Robert et al. Oct 2017 B2
9795729 Childers et al. Oct 2017 B2
D803386 Sabin et al. Nov 2017 S
D803387 Bodwell et al. Nov 2017 S
9808316 Hasegawa Nov 2017 B2
9821151 Juretich et al. Nov 2017 B2
9839743 Lanigan et al. Dec 2017 B2
9839745 Paul et al. Dec 2017 B2
9839775 McGill et al. Dec 2017 B2
9839776 Helmore et al. Dec 2017 B2
9849235 Mandro et al. Dec 2017 B2
9861732 Scarpaci et al. Jan 2018 B2
9861740 Adams Jan 2018 B2
9872950 Kelly et al. Jan 2018 B2
D810958 Lacy et al. Feb 2018 S
9886550 Lee et al. Feb 2018 B2
9895488 Morton Feb 2018 B2
D812218 Lacy et al. Mar 2018 S
9907943 Grant et al. Mar 2018 B2
9925315 Eubanks et al. Mar 2018 B2
9931461 Kamen et al. Apr 2018 B2
9932977 Bresina et al. Apr 2018 B2
9943653 Kamen et al. Apr 2018 B2
9968739 Zollinger et al. May 2018 B2
9976551 Blomquist May 2018 B2
9987410 Helmore et al. Jun 2018 B2
9993600 Lanier, Jr. et al. Jun 2018 B2
10004847 Wander et al. Jun 2018 B2
D823456 Lacy et al. Jul 2018 S
10022494 Shimizu Jul 2018 B2
D828547 Lacy et al. Sep 2018 S
10076608 Dowden et al. Sep 2018 B2
D830546 Lacy et al. Oct 2018 S
D840021 Lacy et al. Feb 2019 S
D846735 Sanborn et al. Apr 2019 S
D870263 Adams et al. Dec 2019 S
D871572 Lacy et al. Dec 2019 S
20010013437 Husted Aug 2001 A1
20010044602 Angersbach et al. Nov 2001 A1
20020107476 Mann et al. Aug 2002 A1
20020134570 Franklin-Lees et al. Sep 2002 A1
20030060765 Campbell et al. Mar 2003 A1
20030161744 Vilks et al. Aug 2003 A1
20030214412 Ho et al. Nov 2003 A1
20040057855 Gerlach et al. Mar 2004 A1
20040167464 Ireland et al. Aug 2004 A1
20040220526 Boyne-Aitken Nov 2004 A1
20060129110 Smith et al. Jun 2006 A1
20060184121 Brockman et al. Aug 2006 A1
20060229577 Roe et al. Oct 2006 A1
20070073236 Mernoe et al. Mar 2007 A1
20070074596 Siefert Apr 2007 A1
20070088249 Duffy et al. Apr 2007 A1
20070167912 Causey et al. Jul 2007 A1
20070179444 Causey et al. Aug 2007 A1
20080103375 Kiani May 2008 A1
20080200870 Palmroos et al. Aug 2008 A1
20080281168 Gibson et al. Nov 2008 A1
20080294142 Patel et al. Nov 2008 A1
20080306437 Jacobson Dec 2008 A1
20090043252 Haylor et al. Feb 2009 A1
20090069749 Miller et al. Mar 2009 A1
20090153058 Feng et al. Jun 2009 A1
20090153463 Arrizza et al. Jun 2009 A1
20090153595 Cozmi et al. Jun 2009 A1
20090157432 Palmroos et al. Jun 2009 A1
20090171289 Davis et al. Jul 2009 A1
20090177180 Rubalcaba, Jr. et al. Jul 2009 A1
20090177991 Davis et al. Jul 2009 A1
20090177992 Rubalcaba, Jr. et al. Jul 2009 A1
20090183105 Teel, IV et al. Jul 2009 A1
20090183147 Davis et al. Jul 2009 A1
20090247982 Krulevitch et al. Oct 2009 A1
20100010647 Schroeder et al. Jan 2010 A1
20100100037 Cozmi et al. Apr 2010 A1
20110040247 Mandro et al. Feb 2011 A1
20110097229 Cauley III et al. Apr 2011 A1
20110106004 Eubanks et al. May 2011 A1
20110106318 Ledford May 2011 A1
20110184383 Hasegawa Jul 2011 A1
20110300010 Jamagin et al. Dec 2011 A1
20110313358 Hariharesan et al. Dec 2011 A1
20120004624 Brown et al. Jan 2012 A1
20120023808 Lagunas-Solar et al. Feb 2012 A1
20120083760 Ledford Apr 2012 A1
20120101437 Gagliardoni et al. Apr 2012 A1
20120130308 Silkaitis et al. May 2012 A1
20120130309 Hariharesan et al. May 2012 A1
20120266964 West et al. Oct 2012 A1
20120266965 Hariharesan et al. Oct 2012 A1
20130053820 Estes et al. Feb 2013 A1
20130115120 Jamagin et al. May 2013 A1
20130131585 Eubanks et al. May 2013 A1
20130267899 Robert et al. Oct 2013 A1
20130272773 Kamen et al. Oct 2013 A1
20130281965 Kamen et al. Oct 2013 A1
20140100526 Ueda et al. Apr 2014 A1
20140188076 Kamen et al. Jul 2014 A1
20140200510 Agard et al. Jul 2014 A1
20140249500 Estes Sep 2014 A1
20140259837 Belliveau Sep 2014 A1
20140271246 Zollinger et al. Sep 2014 A1
20140271247 Abal Sep 2014 A1
20140276424 Davis et al. Sep 2014 A1
20140317929 Robert et al. Oct 2014 A1
20140358111 Brewer et al. Dec 2014 A1
20150018766 Nakanishi et al. Jan 2015 A1
20150023808 Zhu Jan 2015 A1
20150041419 Hawegawa Feb 2015 A1
20150133890 Wander et al. May 2015 A1
20150157791 Desch et al. Jun 2015 A1
20150265768 Vazquez et al. Sep 2015 A1
20150273140 Bresina et al. Oct 2015 A1
20150275887 Koyama et al. Oct 2015 A1
20150297832 Blomquist Oct 2015 A1
20150314066 Shimizu Nov 2015 A1
20160058939 Brewer et al. Mar 2016 A1
20160084434 Janway et al. Mar 2016 A1
20160228633 Welsch et al. Aug 2016 A1
20160235910 Damiano et al. Aug 2016 A1
20160250410 Traversaz et al. Sep 2016 A1
20170028126 Moosai Feb 2017 A1
20170100536 Estes Apr 2017 A1
20170182244 Blomquist Jun 2017 A1
20170189605 Blomquist Jul 2017 A1
20170203032 Dowden et al. Jul 2017 A1
20170213012 O'Scolai et al. Jul 2017 A1
20170258985 Adams et al. Sep 2017 A1
20170277851 Adams et al. Sep 2017 A1
20170281864 Searle et al. Oct 2017 A1
20180117241 Amborn et al. May 2018 A1
20180140770 Hetchler et al. May 2018 A1
20180202429 Bresina et al. Jul 2018 A1
20180353678 Adams et al. Dec 2018 A1
20200179592 Adams et al. Jun 2020 A1
Foreign Referenced Citations (206)
Number Date Country
2009348770 Apr 2015 AU
2010208446 Sep 2015 AU
2011293619 Sep 2015 AU
2010286957 Oct 2015 AU
2009348755 Nov 2015 AU
2010208447 Nov 2015 AU
2010273694 Dec 2015 AU
2011280208 Dec 2015 AU
2012258687 Feb 2016 AU
2013260724 Apr 2016 AU
2015328081 Jul 2016 AU
2015330980 Jul 2016 AU
2012340056 Nov 2016 AU
2014277760 Feb 2017 AU
2016200525 Feb 2017 AU
2012387311 Jul 2017 AU
2015209670 Jul 2017 AU
2014207809 Aug 2017 AU
2013230954 Sep 2017 AU
2015209669 Oct 2017 AU
2014234996 Dec 2017 AU
201810386 Feb 2018 AU
2012258687 Mar 2018 AU
2013361569 May 2018 AU
2014225658 May 2018 AU
2018302257 Jan 2020 AU
2018388965 Jul 2020 AU
2019263493 Nov 2020 AU
2812551 Jun 2015 CA
2711244 Feb 2016 CA
2751513 Apr 2016 CA
2765880 Apr 2016 CA
2712930 Jul 2016 CA
2704411 Sep 2016 CA
2765967 Oct 2016 CA
2765968 Oct 2016 CA
2928503 Oct 2016 CA
2928505 Nov 2016 CA
2709193 Jan 2017 CA
2812555 Feb 2017 CA
2713028 Apr 2017 CA
2712945 Jun 2017 CA
2749557 Jun 2017 CA
2750335 Jun 2017 CA
2702385 Jul 2017 CA
2712947 Jul 2017 CA
2720492 Jul 2017 CA
2866022 Aug 2017 CA
2712950 Oct 2017 CA
2560996 Nov 2017 CA
2772599 Nov 2017 CA
2805738 Nov 2017 CA
3027961 Dec 2017 CA
2768205 Jan 2018 CA
2780286 Jan 2018 CA
2767986 Apr 2018 CA
3069538 Jan 2019 CA
3086175 Jun 2019 CA
179406 Sep 2019 CA
3099115 Nov 2019 CA
101990446 Mar 2011 CN
102065931 May 2011 CN
102292117 Dec 2011 CN
102481447 May 2012 CN
104334209 Feb 2015 CN
104640584 May 2015 CN
201730157329.3 Jul 2018 CN
201830031970.7 Nov 2018 CN
109414545 Mar 2019 CN
110944697 Mar 2020 CN
111683701 Sep 2020 CN
112074313 Dec 2020 CN
4030368 Nov 1991 DE
10348653 May 2005 DE
003933993-0001 May 2017 EM
003933993-0002 May 2017 EM
003933993-0003 May 2017 EM
003933993-0004 May 2017 EM
003933993-0005 May 2017 EM
003934447-0001 May 2017 EM
003934447-0002 May 2017 EM
003934447-0003 May 2017 EM
003934447-0004 May 2017 EM
4680353-0001 Jan 2018 EM
4680353-0002 Jan 2018 EM
4680353-0003 Jan 2018 EM
0477551 Apr 1992 EP
0780134 Jun 1997 EP
0655107 Oct 2002 EP
0999860 Jan 2004 EP
0839062 Sep 2004 EP
1186311 Nov 2004 EP
1616588 Mar 2006 EP
1664536 Oct 2007 EP
1787024 Nov 2009 EP
1768723 Aug 2010 EP
2077874 Sep 2011 EP
1557187 Apr 2012 EP
2445573 Jan 2014 EP
2542781 Mar 2014 EP
2398533 Apr 2014 EP
2298388 Jul 2015 EP
2298389 Aug 2015 EP
2924289 Sep 2015 EP
2596819 Nov 2015 EP
2319551 Jan 2016 EP
1381889 Mar 2016 EP
2254615 Mar 2016 EP
2298378 Mar 2016 EP
2252346 Apr 2016 EP
2519288 Apr 2016 EP
2173433 May 2016 EP
2736551 May 2016 EP
2252347 Jul 2016 EP
2254616 Jul 2016 EP
2570826 Aug 2016 EP
2173402 Sep 2016 EP
2252345 Sep 2016 EP
2453950 Oct 2016 EP
2621452 Nov 2016 EP
2606922 Feb 2017 EP
2197513 Apr 2017 EP
2295091 Apr 2017 EP
2604301 May 2017 EP
2883559 Jun 2017 EP
2902048 Jun 2017 EP
2381978 Jul 2017 EP
2896417 Jul 2017 EP
1680176 Aug 2017 EP
2736564 Aug 2017 EP
1881786 Nov 2017 EP
2183016 Nov 2017 EP
3037117 Dec 2017 EP
2700424 Jan 2018 EP
2260891 Mar 2018 EP
2968741 May 2018 EP
3085402 May 2018 EP
3471796 Apr 2019 EP
3655065 May 2020 EP
3727497 Oct 2020 EP
2302140 Apr 1998 GB
2338992 Sep 2000 GB
61475 Jan 2018 IL
60330 Apr 2018 IL
61476 Apr 2018 IL
61546 Nov 2018 IL
3267404 Mar 2002 JP
3290263 Jun 2002 JP
3382622 Mar 2003 JP
3885018 Feb 2007 JP
3931013 Jun 2007 JP
4394072 Jan 2010 JP
4507233 Jul 2010 JP
4674689 Apr 2011 JP
4805724 Nov 2011 JP
4833732 Dec 2011 JP
4939707 May 2012 JP
2012107555 Jun 2012 JP
2012516208 Jul 2012 JP
5180479 Apr 2013 JP
5235042 Jul 2013 JP
2013153864 Aug 2013 JP
5308575 Oct 2013 JP
5457365 Apr 2014 JP
5543493 Jul 2014 JP
5595930 Sep 2014 JP
5619029 Nov 2014 JP
5720193 May 2015 JP
2015181554 Oct 2015 JP
2016508045 Mar 2016 JP
3378054 Feb 2017 JP
1588670 Sep 2017 JP
1588671 Sep 2017 JP
1591102 Oct 2017 JP
1619335 Nov 2018 JP
2019525784 Sep 2019 JP
2020527417 Sep 2020 JP
423975 Apr 2018 NZ
WO 2001036027 May 2001 WO
WO 2004037322 May 2004 WO
WO 2005037349 Apr 2005 WO
WO 2010023915 Mar 2010 WO
WO 2010088143 Aug 2010 WO
WO 2010088144 Aug 2010 WO
WO 2010149187 Dec 2010 WO
WO 2011008619 Jan 2011 WO
WO 2011008621 Jan 2011 WO
WO 2011008624 Jan 2011 WO
WO 2011025588 Mar 2011 WO
WO 2011025589 Mar 2011 WO
WO 2012009697 Jan 2012 WO
WO 2012039300 Mar 2012 WO
WO 2014089008 Jun 2014 WO
WO 2014100744 Jun 2014 WO
WO 2014159466 Oct 2014 WO
WO 2016014335 Jan 2016 WO
WO 2016018552 Feb 2016 WO
WO 2016179389 Nov 2016 WO
WO 2016183342 Nov 2016 WO
WO 2016196098 Dec 2016 WO
WO 2017218927 Dec 2017 WO
WO 2018022355 Feb 2018 WO
WO 2019018658 Jan 2019 WO
WO 2019055516 Mar 2019 WO
WO 2019125941 Jun 2019 WO
WO 2019213496 Nov 2019 WO
Non-Patent Literature Citations (15)
Entry
US 9,222,472 B2, 12/2015, Gray et al. (withdrawn)
US 9,320,848 B2, 04/2016, Grant et al. (withdrawn)
US 9,867,954 B2, 01/2018, Grant et al. (withdrawn)
DE 4030368C1 translation (Year: 1991).
memteknoloji.com, Stackable Syringe Pump Dixson Instilar 1438, undated online product page, retrieved Sep. 18, 2018 from <URL:http://memteknoloji.com/dixion/www.dixion.de/en/catalogue/intensi-vstation-4/injektionspumpen-4/stapelbare-injektionspumpe-instilar-1438-3.h-tml> (Year: 2018).
Emsworld.com, Space Infusion Pump System, undated online product page, retrieved Sep. 18, 2018 from <URL:https://www.emsworld.com/product/10264356/space-infusion-pump-sys-tem> (Year: 2018).
FMH Employees, “Pediatric Pump Operation: Medfusion Syringe Pump,” Mar. 28, 2012, Retrieved from the Internet (Jun. 27, 2019).
PCT Application No. PCT/US2018/042907, Search Report and Written Opinion dated Jan. 15, 2020, 15 pages.
Application and File History for U.S. Appl. No. 15/733,222, filed Jun. 11, 2020. Inventors: Adams et al.
Application and File History for U.S. Appl. No. 16/309,909, filed Dec. 13, 2018. Inventors: Adams et al.
Application and File History for U.S. Appl. No. 17/250,010, filed Oct. 30, 2020. Inventors: Peterson et al.
Application and File History for U.S. Appl. No. 29/583,354, filed Nov. 4, 2016. Inventors: Lacy et al.
Application and File History for U.S. Appl. No. 29/583,359, filed Sep. 11, 2018. Inventors: Lacy et al.
Application and File History for U.S. Appl. No. 29/583,361, filed Feb. 20, 2018. Inventors: Lacy et al.
Application and File History for U.S. Appl. No. 29/586,520, filed Jul. 17, 2018, Inventors: Lacy et al.
Related Publications (1)
Number Date Country
20200129691 A1 Apr 2020 US
Provisional Applications (1)
Number Date Country
62534407 Jul 2017 US